Bone Grafts and Substitutes - Pipeline Review, 2015 is a new market research publication announced by Reportstack. This report provides an overview of Bone Grafts and Substitutes currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Grafts and Substitutes pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.
Complete report available @ Bone Grafts and Substitutes - Pipeline Review, 2015.
- Extensive coverage of the Bone Grafts and Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Bone Grafts and Substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
aap Implantate AG Accelerated Orthopedic Technologies, Inc. Adaptaide Inc. Adocia Advanced Biologics, LLC Agenta Biotechnologies, Inc. Allergan, Inc. Alphatec Holdings, Inc. Amedica Corporation Anika Therapeutics, Inc. Aperion Biologics Corporation Arthro Kinetics AG Aursos, Inc Berkeley Advanced Biomaterials, Inc. Bio2 Technologies, Inc. Bioactive Bone Substitutes Ltd. Bioregeneration Technologies, Inc Bio-Scaffold International Pte Ltd BioSET, Inc Bioventus LLC Body Organ Biomedical Corp. Bone Solutions, Inc. BoneGrafix, Inc. BoneSupport AB Calcitec, Inc. Cellright Technologies, LLC CeraPedics, Inc. Chinese University of Hong Kong Citrics Biomedical, LLC CollPlant Ltd. ConMed Corporation CoreBone Ltd. ElutInc EpiBone Exactech, Inc. Graftoss Limited Graftys SAS Inion Oy Innovia LLC Innovoss Inc. Integra LifeSciences Holdings Corporation ISTO Technologies, Inc. Jellagen Pty Ltd kasios sas Kytogenics Pharmaceuticals, Inc. Lacerta Technologies GmbH Mariel Therapeutics, Inc. Maxigen Biotech Inc. Medtronic plc Meta Biomed Co., Ltd. Miromatrix Medical Inc. N2 Biomedical National Center of Innovation for Biomaterials in Orthopaedic Research Noraker NovaBone Products, LLC. Nutech Medical, Inc NuVasive, Inc. Orthogen LLC OssiFi, Inc. OsteoNovus, LLC PolyPid, Ltd. Promimic AB ReCaPP Revivicor, Inc. RTI Surgical, Inc. Sanofi SIRAKOSS Limited Soft Tissue Regeneration, Inc. Soteira Inc. Spineway SurgaColl Technologies Ltd TBF Genie Tissulaire The Johns Hopkins University Tissue Regeneration Systems, Inc. Trinity College Dublin University of California, San Diego University of Edinburgh University of Memphis University of Nottingham's School Of Pharmacy University of Pecs University of South Florida Wayne State University Wound Management Technologies, Inc. Wright Medical Group, Inc. X-spine Systems, Inc. Xtant Medical Holdings, Inc.
Manager - Marketing
Reportstack Market Research